Applied DNA Sciences Inc Price to Free Cash Flow Ratio 2010-2024 | APDN
Historical price to free cash flow ratio values for Applied DNA Sciences Inc (APDN) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Applied DNA Sciences Inc Price to Free Cash Flow Ratio Historical Data |
Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
2024-11-21 |
0.16 |
|
0.00 |
2024-06-30 |
0.41 |
$-6.43 |
0.00 |
2024-03-31 |
8.20 |
$-14.20 |
0.00 |
2023-12-31 |
12.34 |
$-11.44 |
0.00 |
2023-09-30 |
24.20 |
$-9.56 |
0.00 |
2023-06-30 |
25.80 |
$-13.58 |
0.00 |
2023-03-31 |
22.60 |
$-14.26 |
0.00 |
2022-12-31 |
33.20 |
$-14.56 |
0.00 |
2022-09-30 |
22.60 |
$-21.11 |
0.00 |
2022-06-30 |
14.76 |
$-30.84 |
0.00 |
2022-03-31 |
42.80 |
$-32.63 |
0.00 |
2021-12-31 |
80.40 |
$-39.81 |
0.00 |
2021-09-30 |
107.80 |
$-46.08 |
0.00 |
2021-06-30 |
135.80 |
$-55.08 |
0.00 |
2021-03-31 |
143.80 |
$-58.52 |
0.00 |
2020-12-31 |
102.00 |
$-55.79 |
0.00 |
2020-09-30 |
154.60 |
$-62.29 |
0.00 |
2020-06-30 |
161.40 |
$-77.92 |
0.00 |
2020-03-31 |
80.40 |
$-85.19 |
0.00 |
2019-12-31 |
83.80 |
$-132.19 |
0.00 |
2019-09-30 |
178.80 |
$-150.34 |
0.00 |
2019-06-30 |
400.00 |
$-178.69 |
0.00 |
2019-03-31 |
570.00 |
$-194.87 |
0.00 |
2018-12-31 |
320.00 |
$-160.14 |
0.00 |
2018-09-30 |
1192.00 |
$-194.81 |
0.00 |
2018-06-30 |
1008.00 |
$-152.99 |
0.00 |
2018-03-31 |
1152.00 |
$-178.27 |
0.00 |
2017-12-31 |
1272.00 |
$-240.57 |
0.00 |
2017-09-30 |
2296.00 |
$-231.23 |
0.00 |
2017-06-30 |
1408.00 |
$-292.07 |
0.00 |
2017-03-31 |
1320.00 |
$-324.52 |
0.00 |
2016-12-31 |
1480.00 |
$-324.74 |
0.00 |
2016-09-30 |
2440.00 |
$-356.70 |
0.00 |
2016-06-30 |
2584.00 |
$-436.36 |
0.00 |
2016-03-31 |
2752.00 |
$-358.04 |
0.00 |
2015-12-31 |
2592.00 |
$-347.34 |
0.00 |
2015-09-30 |
4096.00 |
$-372.47 |
0.00 |
2015-06-30 |
2480.00 |
$-338.65 |
0.00 |
2015-03-31 |
2072.00 |
$-449.93 |
0.00 |
2014-12-31 |
2312.00 |
$-509.68 |
0.00 |
2014-09-30 |
4320.86 |
$-517.47 |
0.00 |
2014-06-30 |
5761.15 |
$-570.63 |
0.00 |
2014-03-31 |
6241.25 |
$-603.69 |
0.00 |
2013-12-31 |
7681.54 |
$-623.01 |
0.00 |
2013-09-30 |
4320.86 |
$-619.97 |
0.00 |
2013-06-30 |
9601.92 |
$-530.71 |
0.00 |
2013-03-31 |
11042.21 |
$-464.31 |
0.00 |
2012-12-31 |
10082.02 |
$-392.56 |
0.00 |
2012-09-30 |
12002.40 |
$-343.57 |
0.00 |
2012-06-30 |
2400.48 |
$-434.29 |
0.00 |
2012-03-31 |
2880.58 |
$-441.55 |
0.00 |
2011-12-31 |
2880.58 |
$-504.36 |
0.00 |
2011-09-30 |
2880.58 |
$-489.53 |
0.00 |
2011-06-30 |
2880.58 |
$-448.10 |
0.00 |
2011-03-31 |
2880.58 |
$-428.09 |
0.00 |
2010-12-31 |
2880.58 |
$-353.90 |
0.00 |
2010-09-30 |
2400.48 |
$-391.59 |
0.00 |
2010-06-30 |
2880.58 |
$-289.19 |
0.00 |
2010-03-31 |
3360.67 |
$-340.04 |
0.00 |
2009-12-31 |
2880.58 |
$-484.96 |
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Industrial Products |
Protection - Safety Equipment & Services |
$0.005B |
$0.013B |
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|